4-tert-butyl-1H-indazol-3-amine

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并吡唑类
• 英文名称: 4-tert-butyl-1H-indazol-3-amine
• 化学式: C₁₁H₁₅N₃
• 分子量: 189.26
• InChiKey: XLTRXFYWEMGCBA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  14
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  54.7
• 氢给体数：
  2
• 氢受体数：
  2

文献信息

• [EN] HETEROCYCLIC COMPOUNDS, PREPARATION METHODS AND USES THEREOF<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES, LEURS PROCÉDÉS DE PRÉPARATION ET LEURS UTILISATIONS
  申请人：INVENTISBIO SHANGHAI LTD

  公开号：WO2020233592A1

  公开（公告）日：2020-11-26

  Provided herein are novel compounds, for example, compounds having a Formula (I) or Formula (II), or a pharmaceutically acceptable salt thereof. Also provided herein are methods of preparing the compounds and methods of using the compounds, for example, in inhibiting KRAS G12C in a cell, and/or in treating various cancer such as pancreatic cancer, endometrial cancer, colorectal cancer, or lung cancer (e.g., non-small cell lung cancer).

  本文提供了新颖的化合物，例如具有化学式(I)或化学式(II)的化合物，或其药用可接受的盐。本文还提供了制备这些化合物的方法以及使用这些化合物的方法，例如，在细胞中抑制KRAS G12C，和/或用于治疗各种癌症，如胰腺癌、子宫内膜癌、结肠癌或肺癌（例如非小细胞肺癌）。
• Bis-aryl amide derivatives and methods of use
  申请人：Booker Shon

  公开号：US20080234268A1

  公开（公告）日：2008-09-25

  Selected compounds are effective for prophylaxis and treatment of diseases, such as c-Met mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

  所选化合物对于预防和治疗疾病，例如c-Met介导的疾病具有有效性。该发明涵盖了新颖的化合物、类似物、前药和其药学上可接受的盐、药物组合物以及预防和治疗涉及癌症等疾病和其他疾病或病情的方法。该发明还涉及用于制备此类化合物的过程以及在此类过程中有用的中间体。
• Heterocyclic compounds, preparation and methods and uses thereof
  申请人：InventisBio Co., Ltd.

  公开号：US11091481B2

  公开（公告）日：2021-08-17

  Provided herein are novel compounds, for example, compounds having a Formula (I) or Formula (II), or a pharmaceutically acceptable salt thereof. Also provided herein are methods of preparing the compounds and methods of using the compounds, for example, in inhibiting KRAS G12C in a cell, and/or in treating various cancer such as pancreatic cancer, endometrial cancer, colorectal cancer, or lung cancer (e.g., non-small cell lung cancer).

  本文提供了新型化合物，例如具有式（I）或式（II）的化合物或其药学上可接受的盐。本文还提供了制备这些化合物的方法和使用这些化合物的方法，例如抑制细胞中的 KRAS G12C，和/或治疗各种癌症，如胰腺癌、子宫内膜癌、结直肠癌或肺癌（如非小细胞肺癌）。
• HETEROCYCLIC COMPOUNDS, PREPARATION AND METHODS AND USES THEREOF
  申请人：InventisBio Co., Ltd.

  公开号：US20210198255A1

  公开（公告）日：2021-07-01

  Provided herein are novel compounds, for example, compounds having a Formula (I) or Formula (II), or a pharmaceutically acceptable salt thereof. Also provided herein are methods of preparing the compounds and methods of using the compounds, for example, in inhibiting KRAS G12C in a cell, and/or in treating various cancer such as pancreatic cancer, endometrial cancer, colorectal cancer, or lung cancer (e.g., non-small cell lung cancer).
• HETEROCYCLIC COMPOUNDS, PREPARATION METHODS AND USES THEREOF
  申请人：InventisBio Co., Ltd.

  公开号：US20210355125A1

  公开（公告）日：2021-11-18

  Provided herein are novel compounds, for example, compounds having a Formula (I) or Formula (II), or a pharmaceutically acceptable salt thereof. Also provided herein are methods of preparing the compounds and methods of using the compounds, for example, in inhibiting KRAS G12C in a cell, and/or in treating various cancer such as pancreatic cancer, endometrial cancer, colorectal cancer, or lung cancer (e.g., non-small cell lung cancer).